David M. Kendall

10.1k citations
107 papers · 7.4k · 3 hit papers · h-index 38

Impact in

Papers in

    • Diabetes Management and Research 31
    • Diabetes Treatment and Management 31
    • Diabetes, Cardiovascular Risks, and Lipoproteins 12
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 9
    • Pancreatic function and diabetes 24

David M. Kendall

102 papers receiving 7.0k citations

David M. Kendall's Hit Papers

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study 2008 · 869 citations
8690+7+14Years since publication250500750

Peers

David M. Kendall
Comparison fields: 5 of 135
  • Endocrinology, Diabetes and Metabolism 4.5k
  • Transplantation 234
  • Surgery 2.4k
  • Pharmacology 776
  • Physiology 831
Replace Jan Bolinder with:
Jan Bolinder Sweden
Maximilian von Eynatten Germany
John P. Bantle United States
Rudolf Prager Austria
C A Cull United Kingdom
Donna Wright United Kingdom
Bruno Vergès France
R R Holman United Kingdom
Matthews United States
Daniel Einhorn United States
David M. Kendall relative to Jan Bolinder Sweden Jan Bolinder's profile →
Citations per field
00.5×1.7×
Jan Bolinder · 1×
Citations per year

Countries citing papers authored by David M. Kendall

Since Specialization
Citations

This map shows the geographic impact of David M. Kendall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Kendall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Kendall more than expected).

Fields of papers citing papers by David M. Kendall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Kendall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Kendall. The network helps show where David M. Kendall may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Kendall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Kendall Line = papers co-authored together David M. Kendall links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea
Hit paper breakdown →
2005964
2
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
Hit paper breakdown →
2008869
3
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
Hit paper breakdown →
2005628
4 2006355
5 2009324
6 2010314
7 2002297
8 2007213
9 1990180
10 1995162
11 2007151
12 2007140
13 2009137
14 2010123
15 1998120
16 2001119
17 1992112
18 2006106
19 2001104
20 200688

About David M. Kendall

David M. Kendall is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pharmacology and Genetics, having authored 107 papers that have together received 7.4k indexed citations. Recurring topics across this work include Diabetes Management and Research (31 papers), Diabetes Treatment and Management (31 papers), Pancreatic function and diabetes (24 papers), Metabolism, Diabetes, and Cancer (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (9 papers), Pharmacology and Obesity Treatment (8 papers) and Diabetes and associated disorders (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.5k citations), Transplantation (234 citations), Surgery (2.4k citations), Pharmacology (776 citations) and Physiology (831 citations). David M. Kendall has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Dongliang Zhuang, John B. Buse, Michael Trautmann, Kristin Taylor, David E.R. Sutherland, Matthew C. Riddle, Dennis Dong Hwan Kim, Mark Fineman, Julio Rosenstock and Alain Baron. Their work appears in journals such as Diabetes, Diabetes Care, Diabetes Technology & Therapeutics, Annals of Surgery and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact